Skip to main content

Table 1 Sample characteristics

From: Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology

 

MCSA (Discovery)

MCSA (Comparison)

ADNI (Replication)

N = 546

N = 953

N = 545

Amyloid positive

Amyloid negative

Amyloid positive

Age (years)

77.0 (7.7)

70.0 (9.7)

76.1 (7.5)

Sex

255 (47%) women

430 (45%) women

260 (48%) women

291 (53%) men

523 (55%) men

285 (52%) men

Education (years)

14.6 (2.8)

14.9 (2.5)

15.9 (2.8)

Median visit number

4 (1.9)

5 (1.8)

4 (1.9)

APOE ɛ4 status

317 (58%) negative

756 (79%) negative

193 (35%) negative

229 (42%) positive

197 (21%) positive

352 (65%) positive

Diagnosisa

458 (85%) CU

887 (93%) CU

103 (19%) CU

78 (14%) MCI

62 (7%) MCI

223 (41%) MCI

6 (1%) Dementia

1 (0%) Dementia

214 (40%) Dementia

  1. Values displayed as mean (standard deviation) or number (percentage)
  2. CU cognitively unimpaired, MCI mild cognitive impairment
  3. aConsensus clinical diagnosis at the first PET/clinical visit; data unavailable for 4 individuals in the MCSA Discovery, 3 individuals in the MCSA Comparison, and 5 individuals in the ADNI replication samples